PRINCETON, NEW JERSEY (January 27, 2022) — Researchers at Princeton University have developed a novel technology to improve the storage and transport of vaccines and life-saving drugs at room temperature. This technology, known as Rapid Room-Temperature Dehydration Technology (RTAD) has been selected for further funding and development by the University City Science Center.
Developed by Princeton Research Scholar Dr. aksim Mezhericher in collaboration with Prof. Howard A. Stone, the innovation involves rapidly dehydrating vaccines and biopharmaceuticals at room temperature using ultra-fine-droplet aerosols, eliminating the need for expensive refrigeration or freezing. The technology has the potential to lower costs and improve the reliability of temperature-sensitive medications and therapies.
Dr. Mezhericher and Prof. Stone received a $200,000 grant from the Science Center’s QED Proof-of-Concept program, with half of the funds contributed by the Science Center and the remainder by the researchers’ institutions. In addition to funding, the awardees received access to business advisers, exposure to investors and industry representatives, and regulatory and legal support. The QED program aims to connect university researchers with experts who help transform life-science discoveries into products and services that benefit human health.
Read more here:
https://www.princeton.edu/news/2022/01/24/thawing-cold-chain-princeton-technology-room-temperature-delivery-vaccines-and